Full video transcriptClick to expand
Auto-generated transcript of @jddenhamfit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Okay my friends, it is time for the peptide of the week.
- 0:04Has it been another week already? Unreal.
- 0:06So this week's peptide of the week is going to be the little orange guy.
- 0:11Five Amino, one in cute. One of my personal favorites and one that I take
- 0:17every single day. Why? Huge on fat burning. It's going to have a light, a
- 0:22fire under that fat. Now a lot of people are going to compare
- 0:26five Amino to a red or true tide. Why? It's going to have that same fat burning
- 0:32quality. It's not a GOP one or weight loss peptide like the red or true tide. It just
- 0:38has that same ability to burn that much back, that quickly.
- 0:42Secondly, it's going to boost your energy. A lot of people ask me,
- 0:46do you have any peptides that are going to help with my energy? I'm always tired all
- 0:50the time. This is going to be the one that's going to fill in the blanks for that.
- 0:53It's going to help boost your metabolism. Now for your gym rat type guys, it's going to help
- 0:59keep muscle on. So if you're in a cut and in a calorie deficit and trying to lean
- 1:04out and like it does burn the fat, it's going to keep the muscle on. So guys like me,
- 1:10that's why I'm running this. Another reason why people compare it to red or true type
- 1:14because it burns fat while you keep muscle. Lastly for you ladies, it's going to be a huge
- 1:20on anti-aging. Again, it's going to be great for your skin. It's going to be great for your
- 1:26nails and your hair and it's going to help bring down inflammation. So again, this isn't my arsenal.
- 1:34I love it. I take it every day. I'm not telling you you should take it. I'm telling you you should
- 1:40research it and then you can make an educated decision if you should take it. I hope this helps.
- 1:46That's all I got.
5-Amino-1MQ for fat loss: what the evidence actually shows
Quick answer
5-amino-1MQ is an experimental NNMT inhibitor with preclinical evidence for fat mass reduction in obese mice (Rhoads et al., 2021), but it has no published human clinical trials, no FDA evaluation, and no established safety profile in people. The fat-burning mechanism differs entirely from GLP-1/GIP-based compounds like retatrutide, making direct comparisons between them unsupported by any published data. Patients interested in metabolic peptide therapy should consult a licensed provider who can assess individual risk factors before considering any investigational compound.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For 5-Amino-1MQ for fat loss: what the evidence actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Triple-Hormone-Receptor Agonist Retatrutide for Obesity, A Phase 2 Trial
Primary human trial source for retatrutide obesity efficacy and safety discussions.
PubMed
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease
Used when retatrutide pages touch liver-fat, MASLD, and metabolic outcomes.
PubMed
Comparison decision path
Use this comparison to narrow the provider review question
Direct answer
5-Amino-1MQ for fat loss: what the evidence actually shows should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
After comparing, use the get-started flow to route your goals and health history into the right prescription review path.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "5-Amino-1MQ for fat loss: what the evidence actually shows" from jddenhamfit. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: 5-amino-1MQ is an experimental NNMT inhibitor with preclinical evidence for fat mass reduction in obese mice (Rhoads et al.
The reason this review is not generic is the source wording and the canonical claim label "peptides the peptide of the week 5 amino 1mq easily one of my persona." In this clip, the useful excerpt is: "Okay my friends, it is time for the peptide of the week." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), Discontinuing glucagon-like peptide-1 receptor agonists and body habitus (2025), and Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
5-amino-1MQ is an experimental NNMT inhibitor with preclinical evidence for fat mass reduction in obese mice (Rhoads et al.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- 5-amino-1MQ is an experimental NNMT inhibitor with preclinical evidence for fat mass reduction in obese mice (Rhoads et al., 2021), but it has no published human clinical trials, no FDA evaluation, and no established safety profile in people. The fat-burning mechanism differs entirely from GLP-1/GIP-based compounds like retatrutide, making direct comparisons between them unsupported by any published data. Patients interested in metabolic peptide therapy should consult a licensed provider who can assess individual risk factors before considering any investigational compound.
- The only published fat-loss study on 5-amino-1MQ is a 2021 mouse study (Rhoads et al., Communications Biology). Zero randomized controlled trials in humans exist as of 2024.
- 5-amino-1MQ works by inhibiting NNMT, a completely different mechanism than GLP-1/GIP receptor agonists like retatrutide. Comparing their fat-burning effects is not supported by any published data.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The only published fat-loss study on 5-amino-1MQ is a 2021 mouse study (Rhoads et al., Communications Biology). Zero randomized controlled trials in humans exist as of 2024.
- 5-amino-1MQ works by inhibiting NNMT, a completely different mechanism than GLP-1/GIP receptor agonists like retatrutide. Comparing their fat-burning effects is not supported by any published data.
- Energy boosting, muscle preservation, and anti-aging effects on skin, hair, and nails are not backed by any peer-reviewed study in humans or animals specific to this compound.
- Because 5-amino-1MQ has no human clinical trials, there is no established safe dose range, no known drug interaction profile, and no regulatory safety data for human use.
- NNMT inhibition is a legitimate area of metabolic research being studied at academic institutions, but interesting preclinical results frequently fail to translate into effective human treatments.
- Buying any research compound without medical supervision means accepting unknown purity, unknown dosing risk, and no clinical follow-up if adverse effects occur.
- Anyone considering experimental peptide therapy should work with a licensed clinician who can review personal health history and monitor outcomes, not act on social media recommendations.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @jddenhamfit actually say?
The creator calls 5-amino-1MQ "one of my personal favorites" and claims he takes it daily. He lists four main benefits: fat burning comparable to retatrutide, energy boosting, muscle preservation during a caloric deficit, and anti-aging effects on skin, hair, and nails. He also says it "brings down inflammation." To his credit, he adds "I'm not telling you you should take it" and encourages personal research before use.
The comparison to retatrutide is the most attention-grabbing claim here. He frames 5-amino-1MQ as having that same ability to "burn that much fat, that quickly" while preserving muscle, which is a bold parallel to one of the more potent investigational weight-loss compounds currently in trials.
Does the science back this up?
Partially, but with serious caveats. The human data on 5-amino-1MQ is essentially nonexistent. What we have is early-stage animal and cell research, and the gap between those findings and the confident claims in this video is significant.
5-amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolism and fat storage. In a 2021 study by Rhoads et al. published in Communications Biology, mice on a high-fat diet treated with 5-amino-1MQ showed reduced fat mass and improved metabolic markers without changes in food intake. That is genuinely interesting data. The same research group published supporting mechanistic work showing NNMT inhibition raises SAM (S-adenosylmethionine) levels and affects fat cell differentiation.
However, mice are not people. There are no published randomized controlled trials in humans. The energy-boosting, hair and nail, and anti-aging claims have no direct published support in any population, human or animal.
What did they get wrong (or right)?
The fat metabolism angle is the most defensible part of this video, because the NNMT inhibition mechanism has legitimate preclinical support. Rhoads et al. (2021, Communications Biology) is a real study with real findings. Crediting 5-amino-1MQ with some metabolic activity is not unreasonable as a hypothesis worth watching.
What he got wrong is the retatrutide comparison. Retatrutide is a GIP, GLP-1, and glucagon triple receptor agonist in Phase 3 trials, with documented efficacy in humans. Saying 5-amino-1MQ has the "same" fat-burning ability is not supported by any comparative data. One is a well-studied peptide hormone analog with human trial results. The other has one mouse study. Framing them as comparable misleads viewers about the evidence hierarchy.
The anti-aging claims for skin, hair, and nails appear to be entirely speculative. NNMT inhibition has been studied in the context of cellular aging in vitro, but there is no published evidence linking 5-amino-1MQ specifically to the cosmetic benefits he describes.
What should you actually know?
5-amino-1MQ is a research compound. That label matters. It means it has not been evaluated for safety, dosing, or efficacy in humans by any regulatory body. Buying it from compounding or research chemical sources means you have no verified purity data, no clinical dosing guidance, and no post-market safety surveillance watching for adverse events.
NNMT inhibition is a genuinely interesting research target. Several academic groups are studying it for obesity, metabolic syndrome, and potentially aging-related conditions. But interesting preclinical data has a long history of not translating into safe, effective human treatments.
The energy-boosting and muscle preservation claims are particularly under-supported. No published mechanism or study directly links 5-amino-1MQ to fatigue reduction or muscle protein synthesis in humans. If you are evaluating this compound for those reasons specifically, you are acting on no evidence.
Anyone considering peptide therapy should have that conversation with a licensed clinician who can review their full health history, not a TikTok video, regardless of how enthusiastic the presenter is about their personal results.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
jddenhamfit · TikTok creator
50.2K views on this video
THE PEPTIDE OF THE WEEK!!! 5 AMINO-1MQ - Easily one of my personal favorites, and one I take daily. I have my bride on it as well. 💥 Here are some of the benefits of this amazing peptide. . . 💊 🔥 1. Helps Burn Fat! It works on an enzyme in your body that plays a role in how fat is stored and used. ⚡ 2. Huge energy boost! Many users say they feel more energized and less sluggish during the day. 💪 3. Helps Keep Muscle It may help you hold onto lean muscle, even while losing fat (great
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the only published fat-loss study on 5-amino-1mq?
The only published fat-loss study on 5-amino-1MQ is a 2021 mouse study (Rhoads et al., Communications Biology). Zero randomized controlled trials in humans exist as of 2024.
What does the video say about 5-amino-1mq works by inhibiting nnmt, a completely different mechanism than?
5-amino-1MQ works by inhibiting NNMT, a completely different mechanism than GLP-1/GIP receptor agonists like retatrutide. Comparing their fat-burning effects is not supported by any published data.
What does the video say about energy boosting, muscle preservation,?
Energy boosting, muscle preservation, and anti-aging effects on skin, hair, and nails are not backed by any peer-reviewed study in humans or animals specific to this compound.
What does the video say about because 5-amino-1mq has no human clinical trials, there?
Because 5-amino-1MQ has no human clinical trials, there is no established safe dose range, no known drug interaction profile, and no regulatory safety data for human use.
What does the video say about nnmt inhibition?
NNMT inhibition is a legitimate area of metabolic research being studied at academic institutions, but interesting preclinical results frequently fail to translate into effective human treatments.
What does the video say about buying any research compound without medical supervision means accepting unknown?
Buying any research compound without medical supervision means accepting unknown purity, unknown dosing risk, and no clinical follow-up if adverse effects occur.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by jddenhamfit, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.